iTonic Holdings Ltd. (NASDAQ:ITOC) — Market Cap & Net Worth
Market Cap & Net Worth: iTonic Holdings Ltd. (ITOC)
iTonic Holdings Ltd. (NASDAQ:ITOC) has a market capitalization of $3.19 Million ($3.19 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29378 globally and #5936 in its home market, demonstrating a -13.96% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying iTonic Holdings Ltd.'s stock price $0.34 by its total outstanding shares 9382000 (9.38 Million). Review total liabilities of iTonic Holdings Ltd. to assess the company's total debt and financial obligations.
iTonic Holdings Ltd. Market Cap History: 2026 to 2026
iTonic Holdings Ltd.'s market capitalization history from 2026 to 2026. Data shows growth from $3.19 Million to $3.19 Million (0.00% CAGR).
iTonic Holdings Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how iTonic Holdings Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ITOC by Market Capitalization
Companies near iTonic Holdings Ltd. in the global market cap rankings as of June 18, 2026.
Key companies related to iTonic Holdings Ltd. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #149 globally with a market cap of $153.89 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #212 globally with a market cap of $115.24 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #236 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #252 globally with a market cap of $100.32 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #149 | Abbott Laboratories | NYSE:ABT | $153.89 Billion | $88.50 |
| #212 | Stryker Corporation | NYSE:SYK | $115.24 Billion | $301.14 |
| #236 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #252 | Medtronic PLC | NYSE:MDT | $100.32 Billion | $78.14 |
iTonic Holdings Ltd. Historical Marketcap From 2026 to 2026
Between 2026 and today, iTonic Holdings Ltd.'s market cap moved from $3.19 Million to $ 3.19 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.19 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of iTonic Holdings Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.19 Million USD |
| MoneyControl | $3.19 Million USD |
| MarketWatch | $3.19 Million USD |
| marketcap.company | $3.19 Million USD |
| Reuters | $3.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About iTonic Holdings Ltd.
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a t… Read more